-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on WAVE Life Sciences, Raises Price Target to $52

Benzinga·03/10/2026 16:04:50
Listen to the news
Canaccord Genuity analyst Whitney Ijem maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $43 to $52.